A role for monoubiquitinated FANCD2 at telomeres in ALT cells

Nucleic Acids Research

Volumn 37, Issue 6, 2009, Pages 1740-1754

  Fan, Qiang ^a   Zhang, Fan ^a   Barrett, Briana ^b   Ren, Keqin ^a   Andreassen, Paul R ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; FANCONI ANEMIA GROUP A PROTEIN; FANCONI ANEMIA GROUP D2 PROTEIN; FANCONI ANEMIA GROUP L PROTEIN; SMALL INTERFERING RNA; TELOMERASE; ATR PROTEIN, HUMAN; CELL CYCLE PROTEIN; PROTEIN SERINE THREONINE KINASE; TELOMERIC REPEAT BINDING FACTOR 1;

ARTICLE; CELL STRAIN; CONTROLLED STUDY; DNA REPAIR; FANCONI ANEMIA; GENETIC RECOMBINATION; GENETIC STABILITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TELOMERE; UBIQUITINATION; CELL LINE; CHEMISTRY; DRUG ANTAGONISM; HELA CELL; METABOLISM; PHYSIOLOGY; SISTER CHROMATID EXCHANGE;

CELL CYCLE PROTEINS; CELL LINE; CELL LINE, TRANSFORMED; FANCONI ANEMIA COMPLEMENTATION GROUP A PROTEIN; FANCONI ANEMIA COMPLEMENTATION GROUP D2 PROTEIN; FANCONI ANEMIA COMPLEMENTATION GROUP L PROTEIN; HELA CELLS; HUMANS; PROTEIN-SERINE-THREONINE KINASES; SISTER CHROMATID EXCHANGE; TELOMERE; TELOMERIC REPEAT BINDING PROTEIN 1; UBIQUITINATION;

EID: 64549109258     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkn995     Document Type: Article

References (66)

1. Alter,B.P. (2003) Cancer in Fanconi anemia, 1927-2001. Cancer, 97, 425-440.
2. Taniguchi,T. and D'Andrea,A.D. (2006) Molecular pathogenesis of Fanconi anemia: Recent progress. Blood, 107, 4223-4233.
3. Garcia-Higuera,I., Taniguchi,T., Ganesan,S., Meyn,M.S., Timmers,C., Hejna,J., Grompe,M. and D'Andrea,A.D. (2001) Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol. Cell, 7, 249-262.
4. Thompson,L.H. (2005) Unraveling the Fanconi anemia-DNA repair connection. Nat. Genet., 37, 921-922.
5. Grompe,M. and van de Vrugt,H. (2007) The Fanconi family adds a fraternal twin. Dev. Cell, 12, 661-662.
6. Taniguchi,T., Garcia-Higuera,I., Xu,B., Andreassen,P.R., Gregory,R.C., Kim,S.T., Lane,W.S., Kastan,M.B. and D'Andrea,A.D. (2002) Convergence of the fanconi anemia and ataxia telangiectasia signaling pathways. Cell 109, 459-472.
7. Montes de Oca,R., Andreassen,P.R., Margossian,S.P., Gregory,R.C., Taniguchi,T., Wang,X., Houghtaling,S., Grompe,M. and D'Andrea,A.D. (2005) Regulated interaction of the Fanconi anemia protein, FANCD2, with chromatin. Blood, 105, 1003-1009.
8. Smogorzewska,A., Matsuoka,S., Vinciguerra,P., McDonald,E.R. 3rd, Hurov,K.E., Luo,J., Ballif,B.A., Gygi,S.P., Hofmann,K., D'Andrea,A.D. et al. (2007) Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair. Cell, 129, 289-301.
9. Taniguchi,T., Garcia-Higuera,I., Andreassen,P.R., Gregory,R.C., Grompe,M. and D'Andrea,A.D. (2002) S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood, 100, 2414-2420.
10. Andreassen,P.R., D'Andrea,A.D. and Taniguchi,T. (2004) ATR couples FANCD2 monoubiquitination to the DNA-damage response. Genes Dev., 18, 1958-1963.
11. Desmaze,C., Soria,J.C., Freulet-Marriere,M.A., Mathieu,N. and Sabatier,L. (2003) Telomere-driven genomic instability in cancer cells. Cancer Lett., 194 173-182.
12. Maser,R.S. and DePinho,R.A. (2002) Connecting chromosomes, crisis, and cancer. Science, 297, 565-569.
13. Reddel,R.R., Bryan,T.M., Colgin,L.M., Perrem,K.T. and Yeager,T.R. (2001) Alternative lengthening of telomeres in human cells. Radiat. Res., 155, 194-200.
14. Henson,J.D., Neumann,A.A., Yeager,T.R. and Reddel,R.R. (2002) Alternative lengthening of telomeres in mammalian cells. Oncogene, 21, 598-610.
15. Dunham,M.A., Neumann,A.A., Fasching,C.L. and Reddel,R.R. (2000) Telomere maintenance by recombination in human cells. Nat. Genet., 26 447-450.
16. Varley,H., Pickett,H.A., Foxon,J.L., Reddel,R.R. and Royle,N.J. (2002) Molecular characterization of inter-telomere and intratelomere mutations in human ALT cells. Nat. Genet., 30, 301-305.
17. Akiyama,K., Yusa,K., Hashimoto,H., Poonepalli,A., Hande,M.P., Kakazu,N., Takeda,J., Tachibana,M. and Shinkai,Y. (2006) Rad54 is dispensable for the ALT pathway. Genes Cells, 11, 1305-1315.
18. Londono-Vallejo,J.A., Der-Sarkissian,H., Cazes,L., Bacchetti,S. and Reddel,R.R. (2004) Alternative lengthening of telomeres is characterized by high rates of telomeric exchange. Cancer Res., 64, 2324-2327.
19. Scheel,C., Schaefer,K.L., Jauch,A., Keller,M., Wai,D., Brinkschmidt,C., van Valen,F., Boecker,W., Dockhorn- Dworniczak,B. and Poremba,C. (2001) Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas. Oncogene, 20, 3835-3844.
20. Chang,S., Khoo,C.M., Naylor,M.L., Maser,R.S. and DePinho,R.A. (2003) Telomere-based crisis: Functional differences between telomerase activation and ALT in tumor progression. Genes Dev., 17, 88-100.
21. Grobelny,J.V., Godwin,A.K. and Broccoli,D. (2000) ALTassociated PML bodies are present in viable cells and are enriched in cells in the G(2)/ M phase of the cell cycle. J. Cell Sci., 113, 4577-4585.
22. Wu,G., Lee,W.H. and Chen,P.L. (2000) NBS1 and TRF1 colocalize at promyelocytic leukemia bodies during late S/G2 phases in immortalized telomerase-negative cells. Implication of NBS1 in alternative lengthening of telomeres. J. Biol. Chem., 275, 30618-30622.
23. Lillard-Wetherell,K., Machwe,A., Langland,G.T., Combs,K.A., Behbehani,G.K., Schonberg,S.A., German,J., Turchi,J.J., Orren,D.K. and Groden,J. (2004) Association and regulation of the BLM helicase by the telomere proteins TRF1 and TRF2. Hum. Mol. Genet., 13, 1919-1932.
24. Wu,G., Jiang,X., Lee,W.H. and Chen,P.L. (2003) Assembly of functional ALT-associated promyelocytic leukemia bodies requires Nijmegen Breakage Syndrome 1. Cancer Res., 63, 2589-2595.
25. Stavropoulos,D.J., Bradshaw,P.S., Li,X., Pasic,I., Truong,K., Ikura,M., Ungrin,M. and Meyn,M.S. (2002) The Bloom syndrome helicase BLM interacts with TRF2 in ALT cells and promotes telomeric DNA synthesis. Hum. Mol. Genet., 11, 3135-3144.
26. Yeager,T.R., Neumann,A.A., Englezou,A., Huschtscha,L.I., Noble,J.R. and Reddel,R.R. (1999) Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Cancer Res., 59, 4175-4179.
27. Grudic,A., Jul-Larsen,A., Haring,S.J., Wold,M.S., Lonning,P.E., Bjerkvig,R. and Boe,S.O. (2007) Replication protein A prevents accumulation of single-stranded telomeric DNA in cells that use alternative lengthening of telomeres. Nucleic Acids Res., 35 7267-7278.
28. Potts,P.R. and Yu,H. (2007) The SMC5/6 complex maintains telomere length in ALT cancer cells through SUMOylation of telomere-binding proteins. Nat. Struct. Mol. Biol., 14, 581-590.
29. Andreassen,P.R. and Margolis,R.L. (1994) Microtubule dependency of p34cdc2 inactivation and mitotic exit in mammalian cells. J. Cell Biol., 127, 789-802.
30. Howlett,N.G., Taniguchi,T., Durkin,S.G., D'Andrea,A.D. and Glover,T.W. (2005) The Fanconi anemia pathway is required for the DNA replication stress response and for the regulation of common fragile site stability. Hum. Mol. Genet., 14, 693-701.
31. Meetei,A.R., de Winter,J.P., Medhurst,A.L., Wallisch,M., Waisfisz,Q., van de Vrugt,H.J., Oostra,A.B., Yan,Z., Ling,C., Bishop,C.E. et al. (2003) A novel ubiquitin ligase is deficient in Fanconi anemia. Nat. Genet., 35, 165-170.
32. Weber,K., Bartsch,U., Stocking,C. and Fehse,B. (2008) A multicolor panel of novel lentiviral "gene ontology" (LeGO) vectors for functional gene analysis. Mol. Ther., 16, 698-706.
33. Zijlmans,J.M., Martens,U.M., Poon,S.S., Raap,A.K., Tanke,H.J., Ward,R.K. and Lansdorp,P.M. (1997) Telomeres in the mouse have large inter-chromosomal variations in the number of T2AG3 repeats. Proc. Natl Acad. Sci. USA, 94, 7423-7428.
34. Bailey,S.M., Brenneman,M.A. and Goodwin,E.H. (2004) Frequent recombination in telomeric DNA may extend the proliferative life of telomerase-negative cells. Nucleic Acids Res., 32, 3743-3751.
35. Rufer,N., Dragowska,W., Thornbury,G., Roosnek,E. and Lansdorp,P.M. (1998) Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry. Nature Biotech., 16, 743-747.
36. Zhu,X.D., Kuster,B., Mann,M., Petrini,J.H. and de Lange,T. (2000) Cell-cycle-regulated association of RAD50/MRE11/NBS1 with TRF2 and human telomeres. Nat. Genet., 25, 347-352.
37. Chong,L., van Steensel,B., Broccoli,D., Erdjument-Bromage,H., Hanish,J., Tempst,P. and de Lange,T. (1995) A human telomeric protein. Science 270, 1663-1667.
38. Molenaar,C., Wiesmeijer,K., Verwoerd,N.P., Khazen,S., Eils,R., Tanke,H.J. and Dirks,R.W. (2003) Visualizing telomere dynamics in living mammalian cells using PNA probes. EMBO J., 22, 6631-6641.
39. Herbig,U., Jobling,W.A., Chen,B.P., Chen,D.J. and Sedivy,J.M. (2004) Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Mol. Cell, 14, 501-513.
40. Williams,E.S., Stap,J., Essers,J., Ponnaiya,B., Luijsterburg,M.S., Krawczyk,P.M., Ullrich,R.L., Aten,J.A. and Bailey,S.M. (2007) DNA double-strand breaks are not sufficient to initiate recruitment of TRF2. Nat. Genet., 39, 696-698.
41. Wang,Y., Erdmann,N., Giannone,R.J., Wu,J., Gomez,M. and Liu,Y. (2005) An increase in telomere sister chromatid exchange in murine embryonic stem cells possessing critically shortened telomeres. Proc. Natl Acad. Sci. USA, 102, 10256-10260.
42. McEachern,M.J. and Haber,J.E. (2006) Break-induced replication and recombinational telomere elongation in yeast. Annu. Rev. Biochem., 75, 111-135.
43. Tarsounas,M. and West,S.C. (2005) Recombination at mammalian telomeres: an alternative mechanism for telomere protection and elongation. Cell Cycle, 4, 672-674.
44. Tarsounas,M., Munoz,P., Claas,A., Smiraldo,P.G., Pittman,D.L., Blasco,M.A. and West,S.C. (2004) Telomere maintenance requires the RAD51D recombination/repair protein. Cell, 117, 337-347.
45. Opresko,P.L., Otterlei,M., Graakjaer,J., Bruheim,P., Dawut,L., Kolvraa,S., May,A., Seidman,M.M. and Bohr,V.A. (2004) The Werner syndrome helicase and exonuclease cooperate to resolve telomeric D loops in a manner regulated by TRF1 and TRF2. Mol. Cell, 14, 763-774.
46. Zhong,Z.H., Jiang,W.Q., Cesare,A.J., Neumann,A.A., Wadhwa,R. and Reddel,R.R. (2007) Disruption of telomere maintenance by depletion of the MRE11/RAD50/NBS1 complex in cells that use alternative lengthening of telomeres. J. Biol. Chem., 282, 29314-29322.
47. Nabetani,A., Yokoyama,O. and Ishikawa,F. (2004) Localization of hRad9, hHus1, hRad1, and hRad17 and caffeine-sensitive DNA replication at the alternative lengthening of telomeres-associated promyelocytic leukemia body. J. Biol. Chem., 279, 25849-25857.
48. Laud,P.R., Multani,A.S., Bailey,S.M., Wu,L., Ma,J., Kingsley,C., Lebel,M., Pathak,S., DePinho,R.A. and Chang,S. (2005) Elevated telomere-telomere recombination in WRN-deficient, telomere dysfunctional cells promotes escape from senescence and engagement of the ALT pathway. Genes Dev., 19, 2560-2570.
49. Erdmann,N., Liu,Y. and Harrington,L. (2004) Distinct dosage requirements for the maintenance of long and short telomeres in mTert heterozygous mice. Proc. Natl Acad. Sci. USA, 101, 6080-6085.
50. Murnane,J.P., Sabatier,L., Marder,B.A. and Morgan,W.F. (1994) Telomere dynamics in an immortal human cell line. EMBO J., 13, 4953-4962.
51. Fasching,C.L., Neumann,A.A., Muntoni,A., Yeager,T.R. and Reddel,R.R. (2007) DNA damage induces alternative lengthening of telomeres (ALT) associated promyelocytic leukemia bodies that preferentially associate with linear telomeric DNA. Cancer Res., 67, 7072-7077.
52. He,H., Multani,A.S., Cosme-Blanco,W., Tahara,H., Ma,J., Pathak,S., Deng,Y. and Chang,S. (2006) POT1b protects telomeres from end-to-end chromosomal fusions and aberrant homologous recombination. EMBO J. 25, 5180-5190.
53. Adelfalk,C., Lorenz,M., Serra,V., von Zglinicki,T., Hirsch-Kauffmann,M. and Schweiger,M. (2001) Accelerated telomere shortening in Fanconi anemia fibroblasts-a longitudinal study. FEBS Lett., 506, 22-26.
54. Leteurtre,F., Li,X., Guardiola,P., Le Roux,G., Sergere,J.C., Richard,P., Carosella,E.D. and Gluckman,E. (1999) Accelerated telomere shortening and telomerase activation in Fanconi's anaemia. Br. J. Haematol., 105, 883-893.
55. Callen,E., Samper,E., Ramirez,M.J., Creus,A., Marcos,R., Ortega,J.J., Olive,T., Badell,I., Blasco,M.A. and Surralles,J. (2002) Breaks at telomeres and TRF2-independent end fusions in Fanconi anemia. Hum. Mol. Genet., 11, 439-444.
56. Franco,S., van de Vrugt,H.J., Fernandez,P., Aracil,M., Arwert,F. and Blasco,M.A. (2004) Telomere dynamics in FANCG-deficient mouse and human cells. Blood, 104, 3927-3935.
57. Yamamoto,K., Ishiai,M., Matsushita,N., Arakawa,H., Lamerdin,J.E., Buerstedde,J.M., Tanimoto,M., Harada,M., Thompson,L.H. and Takata,M. (2003) Fanconi anemia FANCG protein in mitigating radiation- and enzyme-induced DNA double-strand breaks by homologous recombination in vertebrate cells. Mol. Cell Biol., 23, 5421-5430.
58. Nakanishi,K., Yang,Y.G., Pierce,A.J., Taniguchi,T., Digweed,M., D'Andrea,A.D., Wang,Z.Q. and Jasin,M. (2005) Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair. Proc. Natl Acad. Sci. USA, 102, 1110-1115.
59. Yang,Y.G., Herceg,Z., Nakanishi,K., Demuth,I., Piccoli,C., Michelon,J., Hildebrand,G., Jasin,M., Digweed,M. and Wang,Z.Q. (2005) The Fanconi anemia group A protein modulates homologous repair of DNA double-strand breaks in mammalian cells. Carcinogenesis, 26, 1731-1740.
60. Mirchandani,K.D. and D'Andrea,A.D. (2006) The Fanconi anemia/BRCA pathway: A coordinator of cross-link repair. Exp. Cell Res., 312, 2647-2653.
61. Hussain,S., Wilson,J.B., Medhurst,A.L., Hejna,J., Witt,E., Ananth,S., Davies,A., Masson,J.Y., Moses,R., West,S.C. et al. (2004) Direct interaction of FANCD2 with BRCA2 in DNA damage response pathways. Hum. Mol. Genet., 13, 1241-1248.
62. Celli,G.B., Denchi,E.L. and de Lange,T. (2006) Ku70 stimulates fusion of dysfunctional telomeres yet protects chromosome ends from homologous recombination. Nat. Cell Biol., 8, 885-890.
63. Wu,L., Multani,A.S., He,H., Cosme-Blanco,W., Deng,Y., Deng,J.M., Bachilo,O., Pathak,S., Tahara,H., Bailey,S.M. et al. (2006) Pot1 deficiency initiates DNA damage checkpoint activation and aberrant homologous recombination at telomeres. Cell, 126, 49-62.
64. Henson,J.D., Hannay,J.A., McCarthy,S.W., Royds,J.A., Yeager,T.R., Robinson,R.A., Wharton,S.B., Jellinek,D.A., Arbuckle,S.M., Yoo,J. et al. (2005) A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas. Clin. Cancer Res., 11, 217-225.
65. Alter,B.P. (2002) Radiosensitivity in Fanconi's anemia patients. Radiother. Oncol., 62, 345-347.
66. Mokbel,K. (2003) The evolving role of telomerase inhibitors in the treatment of cancer. Curr. Med. Res. Opin., 19, 470-472.